Patent · US Active

RNA interference in dermal and fibrotic indications

US10913948B2 · kind B2 · utility

6Cited by

208References

7Claims

0Family size

Assignee

Phio Pharmaceuticals Corp. · US

Inventors

Anastasia Khvorova · Boulder, US
William Salomon · Worcester, US
Joanne Kamens · Newton, US
Dmitry Samarsky · Berlin, DE
Tod M. Woolf · Sudbury, US
Pamela Pavco · Longmont, US
Lyn Libertine · Framingham, US
James Cardia · Franklin, US
Karen G. Bulock · Mendon, US

Key dates

Filing date	Mar 12, 2018
Grant date	Feb 9, 2021
Priority date	—
Expiry date	Mar 12, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal and fibrotic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.